Project Grant HT94252310649
Award Date
7/1/23
Completion Date
6/30/26
Dollars Obligated
$755K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Charleston, SC 29425, USA
Similar Awards
The Medical University of South Carolina (MUSC) was awarded a $1,185,996.00 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant funding supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The key products and services to be delivered through this 3-year grant, from September 1, 2025 to August 31, 2028, include conducting research to...
The Medical University of South Carolina (MUSC) was awarded a $792,245 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "LEVERAGING LINEAGE ADDICTION: NUCLEAR DELIVERY OF THERAPEUTIC TRANSGENES RESPONSIVE TO ONCOGENIC TRANSCRIPTION FACTOR OVEREXPRESSION," will fund research focused on developing innovative gene therapy approaches to treat various medical conditions. The award has a performance...
This federal Project Grant award in the amount of $906,000.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant titled "Defining and Targeting Cancer Cell-Intrinsic Vulnerabilities in Renal Cell Carcinoma" will be performed by the Medical University of South Carolina (MUSC) from August 1, 2024 to July 31, 2027. Through this funding, MUSC will conduct innovative biomedical research to study novel therapies...
This $1,038,931 federal Project Grant was awarded by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The grant funds research conducted by The Medical University of South Carolina (MUSC) to study SETD2 deficiency and its potential to increase sensitivity to BCL-XL inhibition, which may lead to new treatment approaches. The award has a performance period from September 30, 2024 to September 29, 2028. MUSC, a public university and major...
The Medical University of South Carolina (MUSC) was awarded a $1,503,880 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The three-year grant will fund research into the function of the ARIH1 gene in epithelial-mesenchymal transition (EMT) and tumorigenesis. The Military Medical Research and Development program supports biomedical research that transforms military and public health care through innovative...
The Medical University of South Carolina (MUSC) was awarded a $755,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on July 15, 2024, will support MUSC's research on the role of oxidative stress in heavy metal exposure-induced Alzheimer's disease. This project aims to investigate the link between environmental toxin exposure and the development of neurodegenerative disorders, with a focus on gaining a...
The Medical University of South Carolina (MUSC) has been awarded a $377,498 Project Grant under the Department of Defense's Military Medical Research and Development program (CFDA 12.420). This 3-year grant, effective July 1, 2024, will support MUSC's research project titled "POPULATION-BASED ESTIMATES OF TRAUMATIC BRAIN INJURY AND SUBSEQUENT POST-TRAUMATIC EPILEPSY." The project aims to advance the scientific understanding of the relationship between traumatic brain injury and the...
The Defense Health Agency awarded a $682,049 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
The University of Virginia was awarded a $858,608 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) on August 15, 2025. The grant supports research to understand how melanoma-cognate T-cell help enhances survival with melanoma vaccines. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing biomedical research on innovative cancer treatments. The 3-year grant period will...
The U.S. Defense Health Agency awarded a $1,213,276 Project Grant to Yale University under the Military Medical Research and Development program (CFDA 12.420). This 3-year grant, effective September 1, 2023 through August 31, 2026, will fund research on the role of vascular mimicry in the outgrowth of dormant melanoma micrometastases. The goal of this research is to transform health care for Service Members and the American public through innovative and impactful medical research on solutions...